{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 17
    }
  },
  "results": [
    {
      "discontinued_date": "09/01/2026",
      "update_type": "New",
      "initial_posting_date": "09/01/2026",
      "package_ndc": "0002-7752-05",
      "generic_name": "Insulin Lispro Injection",
      "contact_info": "800-545-5979",
      "related_info": "A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday through Friday from 9am to 8pm for assistance.",
      "openfda": {
        "application_number": [
          "BLA020563"
        ],
        "brand_name": [
          "INSULIN LISPRO JUNIOR KWIKPEN"
        ],
        "generic_name": [
          "INSULIN LISPRO"
        ],
        "manufacturer_name": [
          "Eli Lilly and Company"
        ],
        "product_ndc": [
          "0002-7752",
          "0002-7737",
          "0002-8222"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "INSULIN LISPRO"
        ],
        "rxcui": [
          "242120",
          "1652639",
          "1926331"
        ],
        "spl_id": [
          "6329aa6b-3571-4196-83b0-fc99de56f3ab"
        ],
        "spl_set_id": [
          "97d5e596-aae1-42c9-ae89-c3780959c467"
        ],
        "package_ndc": [
          "0002-7737-01",
          "0002-8222-01",
          "0002-8222-59",
          "0002-7752-01",
          "0002-7752-05"
        ],
        "nui": [
          "N0000004931",
          "N0000175453"
        ],
        "pharm_class_cs": [
          "Insulin [Chemical/Ingredient]"
        ],
        "pharm_class_epc": [
          "Insulin Analog [EPC]"
        ],
        "unii": [
          "GFX7QIS1II"
        ]
      },
      "update_date": "09/01/2026",
      "therapeutic_category": [
        "Endocrinology/Metabolism"
      ],
      "dosage_form": "Injection",
      "presentation": "Insulin Lispro Junior KwikPen, Injection, 100 [iU]/1 mL (NDC 0002-7752-05)",
      "company_name": "Eli Lilly and Co.",
      "status": "To Be Discontinued"
    }
  ]
}